药品信息:
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201991723250311.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- 部分中文Detrol LA处方资料(仅供参考)
【英文名称】Detrol LA
【适用证】
DETROL LA是一种抗毒蕈碱,用于治疗膀胱过度活动症,伴有急迫性尿失禁,尿急和尿频的症状。
【用法用量】
每天口服一次4毫克胶囊,用水冲服并吞服。(2.1)
每天一次口服2毫克胶囊,用水冲服,并在以下情况下吞服:
-----轻度至中度肝功能损害(Child-Pugh A级或B级)(2.2)
-----严重肾功能损害[肌酐清除率(CCr)10-30 mL / min](2.2)
药物是有效的CYP3A4抑制剂。(2.2)
DETROL LA不建议用于CCr <10 mL / min的患者。(2.2)
DETROL LA不建议用于严重肝功能不全患者(Child-Pugh C级)。(2.2)
【禁忌】
DETROL LA禁用于尿潴留,胃潴留或不受控制的窄角型青光眼患者。 DETROL LA也禁用于已知对药物或其成分过敏的患者,或富马酸非索替丁缓释片,如DETROL LA,代谢为5-羟甲基托特罗定。(4)
【INDICATIONS AND USAGE】
DETROL LA is an antimuscarinic indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
【DOSAGE AND ADMINISTRATION】
4 mg capsules taken orally once daily with water and swallowed whole. (2.1)
2 mg capsules taken orally once daily with water and swallowed whole in the presence of:
-----mild to moderate hepatic impairment (Child-Pugh class A or B) (2.2)
-----severe renal impairment [Creatinine Clearance (CCr) 10–30 mL/min] (2.2)
drugs that are potent CYP3A4 inhibitors. (2.2)
DETROL LA is not recommended for use in patients with CCr <10 mL/min. (2.2)
DETROL LA is not recommended for use in patients with severe hepatic impairment (Child-Pugh Class C). (2.2)
【CONTRAINDICATIONS】
DETROL LA is contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. DETROL LA is also contraindicated in patients with known hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended release tablets which, like DETROL LA, are metabolized to 5-hydroxymethyl tolterodine. (4)
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(201991723250311.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- |